NLSP Company Profile and Key Details
NLS Pharmaceutics AG
NLSP Stock Price Chart
Stock Price Today
NLS Pharmaceutics AG (NLSP) stock declined over -6.37%, trading at $1.91 on NASDAQ, down from the previous close of $2.04. The stock opened at $1.96, fluctuating between $1.89 and $2.05 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.
Company Information
| Employees | 6 |
| Beta | -0.52 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
NLS Pharmaceutics AG (NASDAQ: NLSP) stock price is $1.91 in the last trading session. During the trading session, NLSP stock reached the peak price of $2.05 while $1.89 was the lowest point it dropped to. The percentage change in NLSP stock occurred in the recent session was -6.37% while the dollar amount for the price change in NLSP stock was -$0.13.
The NASDAQ listed NLSP is part of Biotechnology industry that operates in the broader Healthcare sector. NLS Pharmaceutics AG designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Christian C. Wenger Dr. iur., L.L.M., LL.M., Ph.D.
Gen. Counsel
Mr. Chad C. Hellmann M.B.A.
Chief Financial Officer
Ms. Sharon Keys
Head of Regulatory Affairs
Mr. Keith Harrison Dewedoff
Chief Financial Officer
Mr. Eric Konofal M.D., Ph.D.
Chief Scientific Officer
Mr. Alexander Zwyer M.B.A.
Pres, Chief Executive Officer & Director
Dr. George Apostol M.D.
Chief Medical Officer and Global Head of R&D
NLSP's closing price is 10.4% higher than its 52-week low of $1.73 where as its distance from 52-week high of $20.80 is -90.82%.
Number of NLSP employees currently stands at 6.
Official Website of NLSP is: https://nlspharma.com
NLSP could be contacted at phone 414 451 22150 and can also be accessed through its website. NLSP operates from The Circle 6, Zurich, 8058, Switzerland.
NLSP stock volume for the day was 118.43K shares. The average number of NLSP shares traded daily for last 3 months was 1.06M.
The market value of NLSP currently stands at $4.72M with its latest stock price at $1.91 and 2.47M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com